
Tacrolimus
Tacrolimus is a standard anti-rejection drug after kidney, liver, heart and lung transplants. Compared with cyclosporine, it reduced rejection and graft loss after kidney transplant and reduced deaths and graft loss after liver transplant in pooled trials, at the cost of more new diabetes. Several supplements and foods change its blood level, including St. John's wort, CBD, grapefruit and pomelo.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Organ transplant recipients, as part of a combination prescribed and monitored by a transplant team
Common dosing range
Set by the transplant team and adjusted to whole-blood trough levels. Prograf label starting doses range from 0.075 to 0.2 mg/kg a day in two doses every 12 hours, depending on the organ and other drugs
When to expect effects
Works from the first doses; blood levels are checked often in the first weeks and after any change in medicines or diet
Watch out for
Its blood level shifts easily with other drugs, supplements and foods; too low risks rejection and too high harms the kidneys and nerves. It also commonly lowers magnesium (34 percent of kidney patients on Prograf with azathioprine in one trial) and can raise potassium. Do not add a magnesium or potassium supplement on your own; ask your transplant team whether your levels need treatment.
What is it
Tacrolimus is a prescription immunosuppressant, a calcineurin inhibitor, taken after an organ transplant to stop the immune system from rejecting the new organ. Prograf (capsules, granules for oral suspension and an injection) is labeled for kidney, liver, heart and lung transplants; the once-daily extended-release products Envarsus XR and Astagraf XL are labeled for kidney transplants. Immediate-release and extended-release forms are not interchangeable, and a transplant team adjusts the dose to blood levels. This page covers tacrolimus taken by mouth or vein; tacrolimus ointment for eczema is a different product.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
preventing rejection after kidney transplant Good Evidence | About 44 percent less graft loss at 6 months and 31 percent less acute rejection at 1 year than cyclosporine | Adult kidney transplant recipients | From the first months after transplant |
survival and graft survival after liver transplant Good Evidence | About 15 percent fewer deaths and 27 percent fewer graft losses at 1 year than cyclosporine | Adults receiving a first liver transplant | First year after transplant |
preventing rejection after kidney transplant
- Effect
- About 44 percent less graft loss at 6 months and 31 percent less acute rejection at 1 year than cyclosporine
- Best fit
- Adult kidney transplant recipients
- Time
- From the first months after transplant
survival and graft survival after liver transplant
- Effect
- About 15 percent fewer deaths and 27 percent fewer graft losses at 1 year than cyclosporine
- Best fit
- Adults receiving a first liver transplant
- Time
- First year after transplant
Evidence for 2 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
preventing rejection after kidney transplant
Disease adjunctA meta-analysis of 30 randomized trials (4,102 kidney transplant recipients) compared tacrolimus with cyclosporine as the main anti-rejection drug. Tacrolimus reduced graft loss at 6 months (relative risk 0.56), an effect that lasted up to 3 years, and reduced acute rejection at 1 year (relative risk 0.69) and steroid-resistant rejection (0.49). It caused more insulin-requiring diabetes (relative risk 1.86), tremor, headache and stomach upset. The authors estimated that treating 100 recipients with tacrolimus instead of cyclosporine for a year avoids 12 acute rejections and 2 graft losses but causes 5 extra cases of insulin-dependent diabetes. In the later ELITE-Symphony trial of 1,645 kidney recipients, a low-dose tacrolimus regimen had the best kidney function at 12 months, the fewest biopsy-proven rejections (12.3 percent versus 24.0 to 37.2 percent) and the highest graft survival (94.2 percent) among four regimens.
Bottom line: Fewer rejections and graft losses than cyclosporine after kidney transplant, with more new diabetes.
survival and graft survival after liver transplant
Disease adjunctA Cochrane review of 16 randomized trials (3,813 first-time liver transplant recipients) compared tacrolimus with cyclosporine. At 1 year, tacrolimus reduced death (relative risk 0.85), graft loss (0.73), acute rejection (0.81) and steroid-resistant rejection (0.54), but caused more new insulin-requiring diabetes (1.38). Fewer patients stopped tacrolimus than cyclosporine. Per 100 patients treated with tacrolimus instead of cyclosporine, the reviewers estimated 2 fewer deaths, 5 fewer graft losses and 9 fewer acute rejections, but 4 more cases of diabetes.
Bottom line: After liver transplant, tacrolimus improved survival and graft survival over cyclosporine.
How it works
How to take it
What to track
Bottom line: Your transplant team sets the dose by blood levels; check every supplement and diet change with them first.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Boxed warning: increased risk of serious infections and of cancers, including lymphoma and skin cancer, which may lead to hospitalization or death. The label advises limiting sun and UV exposure. Astagraf XL also carries a boxed warning for increased deaths in female liver transplant patients and is not approved for liver transplant.
Kidney damage (nephrotoxicity), reported in about 52 percent of kidney transplant patients in Prograf trials, with a higher risk when levels are high or other kidney-toxic drugs are used
Nervous system toxicity, from tremor and headache to seizures, delirium, coma and posterior reversible encephalopathy syndrome (PRES), often with levels at or above the target range
New-onset diabetes after transplant, with higher risk in African-American and Hispanic kidney transplant patients; it may be reversible in some
High potassium. The label advises monitoring potassium and careful thought before adding other drugs that raise it, such as potassium-sparing diuretics, ACE inhibitors and ARBs.
Low magnesium, reported in 34 percent of kidney transplant patients on Prograf with azathioprine versus 17 percent on cyclosporine with azathioprine. Low magnesium, potassium or calcium also adds to the risk of QT prolongation, a heart rhythm problem tacrolimus can cause.
Medication errors from swapping immediate-release and extended-release tacrolimus, which have caused rejection or overexposure; check that the product you receive matches what was prescribed
Who should avoid it
- People allergic to tacrolimus, or (for the injection) to polyoxyl 60 hydrogenated castor oil
- People with congenital long QT syndrome (the label says to avoid it)
- Use with cyclosporine at the same time is not recommended (one is stopped at least 24 hours before starting the other), and use with sirolimus is not recommended after liver or heart transplant
Pregnancy & breastfeeding
The label says tacrolimus can cause fetal harm: registry and postmarketing data suggest a risk of prematurity, birth defects, low birth weight and fetal distress, and newborns have had kidney problems and high potassium. Tacrolimus passes into breast milk. Female and male patients are advised to discuss family planning and contraception with their transplant team before starting; a pregnancy registry (Transplantation Pregnancy Registry International) follows outcomes. Do not stop tacrolimus because of a pregnancy without your team.
Interactions
St. John's wort speeds up the CYP3A enzymes that clear tacrolimus. In 10 stable kidney transplant patients, 600 mg a day of St. John's wort extract for 14 days cut tacrolimus exposure by more than half (dose-corrected AUC from 180 to 75.9 ng/mL/h), and the median dose had to rise from 4.5 to 8.0 mg a day to stay in range, then fell again after the herb was stopped. The label lists it as a strong inducer that raises rejection risk. Do not combine them; if you already take it, tell your transplant team before stopping so they can check levels through the change.
Grapefruit permanently disables the CYP3A enzyme in the gut wall, so more tacrolimus is absorbed; the body needs new enzyme to recover, with a half-life of about 23 hours, so spacing grapefruit away from your dose does not prevent the effect. A kidney transplant patient's tacrolimus level about doubled with no dose change after eating grapefruit, and the Prograf and Envarsus XR labels say to avoid grapefruit and grapefruit juice because high levels raise the risk of neurotoxicity and QT prolongation. If you eat some by mistake, take your next dose as prescribed and tell your transplant team.
Pomelo is a grapefruit relative. A published case described a considerable rise in tacrolimus blood level in a kidney transplant recipient after eating pomelo, likely from blocking CYP3A4, P-glycoprotein or both, and the authors advised people on tacrolimus or cyclosporine to avoid pomelo and other grapefruit-related citrus. Ask your transplant team about other bitter citrus, such as Seville orange, before eating it regularly.
In 12 healthy adults, CBD at 5 mg/kg twice daily for 14 days raised the peak level of a single tacrolimus dose 4.2-fold and total exposure 3.1-fold. The Prograf label now advises close monitoring of tacrolimus levels and possible dose reduction when CBD is used. That trial used a high, prescription-level CBD dose, so the effect of smaller consumer doses is less certain; treat any start, stop or change in a CBD product like a medication change and tell your transplant team first.
Lactobacillus rarely infects healthy people, but it can cause bloodstream infections when the immune system is suppressed. A kidney transplant recipient on tacrolimus, mycophenolate and prednisone developed Lactobacillus rhamnosus bacteremia with septic shock; he had taken a Lactobacillus probiotic for five months, though the strain in his blood differed from the product's strains. Many Lactobacillus strains resist vancomycin, which makes treatment harder. Do not start a probiotic without your transplant team's approval, and report fever or chills promptly.
Live probiotic organisms can occasionally enter the bloodstream when the immune system is suppressed. In a cluster of 6 children after stem cell transplant, genome sequencing showed that the Lactobacillus in their blood was related to the probiotic they had taken. A hospital case-control study in adults also linked such infections strongly to probiotic use, although they were rare overall. Because tacrolimus suppresses the immune system, review any probiotic with your transplant team before using it.
Schisandra sphenanthera extract, sold as Wuzhi capsules, blocks the CYP3A enzyme and P-glycoprotein that clear tacrolimus; in 12 healthy men it raised tacrolimus exposure by 164 percent on average, and the label lists it with the strong CYP3A inhibitors. Schisandra chinensis berry supplements have not been tested with tacrolimus in people but contain related CYP3A-blocking lignans. Do not start or stop any schisandra product without your transplant team.
The Envarsus XR, Astagraf XL and generic tacrolimus extended-release capsule labels tell patients to avoid alcoholic beverages because alcohol may change how fast these extended-release forms release tacrolimus, which the Astagraf XL and generic extended-release capsule labels link to a higher risk of nerve toxicity and QT prolongation. The immediate-release Prograf label has no alcohol warning, and the ointment label notes that alcohol can cause facial flushing. Ask your transplant team what applies to the form you take.
Tacrolimus can raise blood potassium; high potassium was among the most common side effects in the Prograf transplant trials, and the label asks prescribers to monitor potassium and weigh other potassium-raising agents carefully. Potassium supplements and potassium-based salt substitutes add potassium directly, and high potassium is usually silent until it affects the heart. Use them only when your transplant team has ordered them and is checking your levels.
These drugs can cause a rapid, sharp rise in tacrolimus levels, even after the dose is lowered. The label calls for dose reduction (to one third for voriconazole and posaconazole) and level checks starting within 1 to 3 days. The label also lists Schisandra sphenanthera extracts in this group.
These drugs lower tacrolimus levels and raise the risk of rejection. The label advises increasing the tacrolimus dose and monitoring trough levels when they are used together.
The label says to avoid live vaccines during tacrolimus treatment, such as intranasal flu, measles-mumps-rubella, varicella, yellow fever, BCG and oral typhoid. Inactivated vaccines may work less well. Ask your transplant team which vaccines you need and when.
Cranberry has been shown to inhibit the gut CYP3A enzyme, which would be expected to raise tacrolimus levels, but a published case report went the other way: a 40-year-old kidney transplant patient taking cranberry extract capsules for urinary infections had low tacrolimus levels that barely rose with a higher dose and returned to range after she stopped the cranberry. The authors found no earlier reports of this pair. Because the direction is unpredictable, talk to your transplant team before starting or stopping cranberry products, and ask about a level check after any change.
In a healthy-volunteer study described in the label, a magnesium-aluminum hydroxide antacid raised tacrolimus exposure by 21 percent and lowered its peak by 10 percent, and the label says to monitor levels and lower the dose if needed. In a lab study, magnesium antacids also broke tacrolimus down in simulated stomach fluid, so the effect in a given person is hard to predict. Tell your transplant team about regular use and ask your pharmacist about timing.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (10)
+ st. john's wort
criticalSt. John's wort induces the CYP3A4 enzyme and the P-glycoprotein transporter, which speeds up clearance of tacrolimus and lowers its blood levels, raising the risk of transplant rejection. Stopping the herb lets tacrolimus levels climb back up, which can push them too high if the dose was raised in the meantime; high tacrolimus levels can harm the kidneys.
+ alcohol
highThe labels for the extended-release tacrolimus products (Envarsus XR, Astagraf XL and generic tacrolimus extended-release capsules) tell patients to avoid alcoholic beverages, because alcohol may change how fast tacrolimus is released; the Astagraf XL and generic extended-release capsule labels say it may speed release and raise the risk of serious side effects such as nerve toxicity and QT prolongation. The label for immediate-release Prograf has no alcohol warning, and the tacrolimus ointment label notes that drinking alcohol can make the skin or face flushed and hot. These are label precautions: the labels do not describe a human study measuring how much alcohol changes tacrolimus levels.
+ cbd
highCBD inhibits CYP3A4, CYP3A5, and P-glycoprotein, the main pathways that clear tacrolimus. Case reports and a controlled pharmacokinetic trial show that adding CBD raises tacrolimus blood levels substantially, risking nephrotoxicity, neurotoxicity, and over-immunosuppression in transplant recipients, while stopping CBD abruptly can let levels crash and risk rejection.
+ lactobacillus
highTacrolimus is a calcineurin-inhibitor immunosuppressant used after solid-organ transplant. In immunosuppressed transplant recipients, Lactobacillus probiotic organisms can cross the gut wall and cause bloodstream infection. A published case report describes Lactobacillus rhamnosus bacteremia with septic shock in a kidney transplant patient on tacrolimus, and its authors note only a handful of such cases in transplant recipients. Many Lactobacillus strains are intrinsically vancomycin-resistant, making treatment harder.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I take St. John's wort with tacrolimus?⌄
No. In kidney transplant patients, two weeks of St. John's wort cut tacrolimus exposure by more than half, and the label lists it with drugs that raise the risk of rejection. If you are already taking it, do not just stop: tell your transplant team, because your tacrolimus level can climb again after the herb is stopped and they may need to adjust your dose and check levels.
Is grapefruit really a problem with tacrolimus?⌄
Yes. The labels say to avoid grapefruit and grapefruit juice, because grapefruit disables the gut enzyme that limits tacrolimus absorption and the effect lasts long after you eat it, so spacing it from your dose does not help. A kidney transplant patient's level about doubled after eating grapefruit. Pomelo has caused the same problem. Sweet oranges are not part of this warning; ask your team about other citrus.
Is CBD safe with tacrolimus?⌄
CBD can raise tacrolimus levels a lot: in a trial in healthy adults, high-dose CBD tripled tacrolimus exposure. The Prograf label advises closer level monitoring and possible dose reduction with CBD. Do not start or stop CBD without telling your transplant team.
Can I take probiotics after a transplant on tacrolimus?⌄
Ask your transplant team first. Probiotic organisms such as Lactobacillus have caused rare but serious bloodstream infections in people with suppressed immune systems, including a kidney transplant patient on tacrolimus. Report fever or chills promptly.
Tacrolimus lowered my magnesium. Should I take a magnesium supplement?⌄
Low magnesium is common on tacrolimus (34 percent of kidney patients in one trial), and your team usually checks it. Do not add a supplement on your own: antacids containing magnesium and aluminum hydroxide raised tacrolimus exposure by 21 percent in a label study, and your team may prefer a specific product and timing. Ask your transplant team whether your level needs treatment.
References by claim
preventing rejection after kidney transplant
survival and graft survival after liver transplant
Haddad et al., 2006 · PMC (2006) link
Safety
Interaction: St. John's wort
Mai et al., 2003 · PubMed (2003) link
Interaction: Grapefruit and grapefruit juice
Interaction: Pomelo
Egashira et al., 2003 · PubMed (2003) link
Interaction: CBD (cannabidiol)
So et al., 2025 · PMC (2025) link
Interaction: Lactobacillus probiotics
Sendil et al., 2020 · PMC (2020) link
Interaction: Other probiotic supplements (Bifidobacterium, Lactococcus, Saccharomyces, probiotic kefir and yogurt drinks)
Interaction: Schisandra (Wuzhi capsules, schisandra berry)
Xin et al., 2007 · PMC (2007) link
Interaction: Alcohol (extended-release tacrolimus)
Interaction: Potassium supplements and potassium salt substitutes
Interaction: Cranberry juice and cranberry extract
Dave et al., 2016 · PMC (2016) link
Interaction: Magnesium hydroxide antacids (Milk of Magnesia, some Maalox and Mylanta liquids)
Steeves et al., 1991 · PMC (1991) link
Track Tacrolimus with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
